Literature DB >> 10560807

Metabolic aspects of continuous renal replacement therapies.

W Druml1.   

Abstract

Continuous renal replacement therapies (CRRTs) are associated with a broad pattern of additional metabolic effects beyond renal detoxification. Because of the continuous mode of therapy and the high fluid turnover usually associated with CRRTs, these side effects can become clinically relevant. With many CRRT systems currently used, heat loss is considerable, but CRRTs can also be used to modulate body temperature in hyperpyretic patients. Inappropriate glucose concentrations of some substitution fluids can result in excessive glucose intake. Most substitution and/or dialysate fluids used for CRRTs contain lactate as organic anion. In disease states with impaired lactate utilization, such as acute or chronic liver failure, and/or with increased endogenous lactate formation such as in shock states, this can result in hyperlactemia and is potentially associated with various adverse side effects. Small molecular weight substances such as amino acids or water-soluble vitamins are lost in relevant amounts. With convective clearance and the high molecular cut-off of synthetic membranes, medium-sized molecules such as hormones and cytokines are also filtered, but the pathophysiologic relevance of this observation remains to be specified. Moreover, synthetic membranes used for CRRTs have adsorptive properties for a variety of molecules, such as cytokines, complement factors, and endotoxin. Continuous blood membrane interactions cause the phenomena of bioincompatibility and a low-grade inflammatory reaction with potentially adverse consequences on protein metabolism and immunocompetence. In designing a nutritional program for a patient on CRRT, these metabolic effects--especially the loss of nutritional substrates--must be considered. Certainly, most of these side effects, such as the excessive load of lactate or the loss of nutrients, are undesirable. However, some side effects, such as the modulation of body temperature and the elimination of endotoxin and/or mediators, might be at least potentially beneficial.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560807

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  16 in total

Review 1.  Acute renal failure is not a "cute" renal failure!

Authors:  Wilfred Druml
Journal:  Intensive Care Med       Date:  2004-06-15       Impact factor: 17.440

2.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

3.  Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.

Authors:  Sandra N Stapel; Ruben J de Boer; Patrick J Thoral; Marc G Vervloet; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Blood Purif       Date:  2019-07-10       Impact factor: 2.614

Review 4.  Nutritional management in the critically ill child with acute kidney injury: a review.

Authors:  Sidharth Kumar Sethi; Norma Maxvold; Timothy Bunchman; Pranaw Jha; Vijay Kher; Rupesh Raina
Journal:  Pediatr Nephrol       Date:  2016-06-20       Impact factor: 3.714

Review 5.  Continuous renal replacement therapies: a brief primer for the neurointensivist.

Authors:  Pritesh Patel; Veena Nandwani; Paul J McCarthy; Steven A Conrad; L Keith Scott
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 6.  [Nutrition and renal insufficiency].

Authors:  W Druml
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-06-08       Impact factor: 0.840

7.  Continuous renal replacement therapy: a potential source of calories in the critically ill.

Authors:  Andrea M New; Erin M Nystrom; Erin Frazee; John J Dillon; Kianoush B Kashani; John M Miles
Journal:  Am J Clin Nutr       Date:  2017-05-03       Impact factor: 7.045

8.  Prognosis of acute renal failure: an evaluation of proposed consensus criteria.

Authors:  M E Ostermann; R W S Chang
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

9.  More interventions do not necessarily improve outcome in critically ill patients.

Authors:  Philipp G H Metnitz; Ana Reiter; Barbara Jordan; Thomas Lang
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

Review 10.  Parenteral nutrition in patients with renal failure - Guidelines on Parenteral Nutrition, Chapter 17.

Authors:  W Druml; H P Kierdorf
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.